Ajax loader

Can't find what you're looking for?

 

Be sure to Sign in to see all available content.

 

If you don't have an account, Register here.

Search results for: Antibody

HEALTH-CORONAVIRUS/USA
RTS4X21R 
January 27, 2022 
A registered nurse (RN) administers Intravenous Monoclonal Antibody to a coronavirus disease (COVID-19)... 
Mission Viejo, UNITED STATES 
COVID-19 care in the Emergency Department in Providence Mission Hospital in Mission Viejo, California... 
A registered nurse (RN) administers Intravenous Monoclonal Antibody to a coronavirus disease (COVID-19) patient in a respiratory isolation room in the emergency room at Providence Mission Hospital in Mission Viejo, California, U.S., January 27, 2022. REUTERS/Shannon Stapleton 
HEALTH-CORONAVIRUS/USA
RTS4K32V 
January 15, 2022 
A patient who is being treated for the coronavirus disease (COVID-19) undergoes a monoclonal antibody... 
Augusta, UNITED STATES 
COVID-19 positive patients receive care at Georgia children's hospital 
A patient who is being treated for the coronavirus disease (COVID-19) undergoes a monoclonal antibody treatment at the Children's Hospital of Georgia in Augusta, Georgia, U.S., January 15, 2022. REUTERS/Hannah Beier 
HEALTH-CORONAVIRUS/USA
RTS4K32Y 
January 15, 2022 
Brooke Cobb, RN, flushes a monoclonal antibody treatment from a patient who is being treated for the... 
Augusta, UNITED STATES 
COVID-19 positive patients receive care at Georgia children's hospital 
Brooke Cobb, RN, flushes a monoclonal antibody treatment from a patient who is being treated for the coronavirus disease (COVID-19) at the Children's Hospital of Georgia in Augusta, Georgia, U.S., January 15, 2022. REUTERS/Hannah Beier 
HEALTH-CORONAVIRUS/USA
RTS4K31L 
January 15, 2022 
A patient who is being treated for the coronavirus disease (COVID-19) undergoes a monoclonal antibody... 
Augusta, UNITED STATES 
COVID-19 positive patients receive care at Georgia children's hospital 
A patient who is being treated for the coronavirus disease (COVID-19) undergoes a monoclonal antibody treatment at the Children's Hospital of Georgia in Augusta, Georgia, U.S., January 15, 2022. REUTERS/Hannah Beier 
HEALTH-CORONAVIRUS/USA
RTS4K31K 
January 15, 2022 
Brooke Cobb, RN, administers a monoclonal antibody treatment to a patient who is being treated for the... 
Augusta, UNITED STATES 
COVID-19 positive patients receive care at Georgia children's hospital 
Brooke Cobb, RN, administers a monoclonal antibody treatment to a patient who is being treated for the coronavirus disease (COVID-19) at the Children's Hospital of Georgia in Augusta, Georgia, U.S., January 15, 2022. REUTERS/Hannah Beier 
HEALTH-CORONAVIRUS/USA
RTS4K2YU 
January 15, 2022 
Brooke Cobb, RN, administers a monoclonal antibody treatment to a patient who is being treated for the... 
Augusta, UNITED STATES 
COVID-19 positive patients receive care at Georgia children's hospital 
Brooke Cobb, RN, administers a monoclonal antibody treatment to a patient who is being treated for the coronavirus disease (COVID-19) at the Children's Hospital of Georgia in Augusta, Georgia, U.S., January 15, 2022. REUTERS/Hannah Beier 
HEALTH-CORONAVIRUS/USA
RTS43FZK 
December 29, 2021 
A sign advertises Gothams' "Monoclonal Antibody Infusion Center" for coronavirus disease patients at... 
Everett, UNITED STATES 
A sign advertises Gothams' "Monoclonal Antibody Infusion Center" in Everett 
A sign advertises Gothams' "Monoclonal Antibody Infusion Center" for coronavirus disease patients at the CHA Everett Hospital in Everett, Massachusetts, U.S., December 29, 2021. According to the state government, the "DPH has contracted with Gothams to facilitate the opening of three mobile sites for monoclonal antibody therapy for high-risk patients who have been exposed to or have COVID-19." REUTERS/Brian Snyder 
HEALTH-CORONAVIRUS/USA
RTS43FZN 
December 29, 2021 
A sign advertises Gothams' "Monoclonal Antibody Infusion Center" for coronavirus disease patients at... 
Everett, UNITED STATES 
A sign advertises Gothams' "Monoclonal Antibody Infusion Center" in Everett 
A sign advertises Gothams' "Monoclonal Antibody Infusion Center" for coronavirus disease patients at the CHA Everett Hospital in Everett, Massachusetts, U.S., December 29, 2021. According to the state government, the "DPH has contracted with Gothams to facilitate the opening of three mobile sites for monoclonal antibody therapy for high-risk patients who have been exposed to or have COVID-19." REUTERS/Brian Snyder 
HEALTH-CORONAVIRUS/USA
RTS43FZJ 
December 29, 2021 
A sign advertises Gothams' "Monoclonal Antibody Infusion Center" for coronavirus disease patients at... 
Everett, UNITED STATES 
A sign advertises Gothams' "Monoclonal Antibody Infusion Center" in Everett 
A sign advertises Gothams' "Monoclonal Antibody Infusion Center" for coronavirus disease patients at the CHA Everett Hospital in Everett, Massachusetts, U.S., December 29, 2021. According to the state government, the "DPH has contracted with Gothams to facilitate the opening of three mobile sites for monoclonal antibody therapy for high-risk patients who have been exposed to or have COVID-19." REUTERS/Brian Snyder 
HEALTH-CORONAVIRUS/USA
RTS43FZL 
December 29, 2021 
A sign advertises Gothams' "Monoclonal Antibody Infusion Center" for coronavirus disease patients at... 
Everett, UNITED STATES 
A sign advertises Gothams' "Monoclonal Antibody Infusion Center" in Everett 
A sign advertises Gothams' "Monoclonal Antibody Infusion Center" for coronavirus disease patients at the CHA Everett Hospital in Everett, Massachusetts, U.S., December 29, 2021. According to the state government, the "DPH has contracted with Gothams to facilitate the opening of three mobile sites for monoclonal antibody therapy for high-risk patients who have been exposed to or have COVID-19." REUTERS/Brian Snyder 
HEALTH-CORONAVIRUS/ C
RTXKSKMP 
November 29, 2021 
UPDATE updated Dec 15 "The World Health Organization classified Omicron as a "variant of concern," due... 
UNITED STATES 
UPDATE OMICRON VARIANT MAP C 
UPDATE updated Dec 15 "The World Health Organization classified Omicron as a "variant of concern," due to the number of mutations that might help it spread or evade antibodies from prior infection or vaccination. 
HEALTH-CORONAVIRUS/AUSTRALIA
RTXKRDIX 
November 29, 2021 
A medical worker holds a tray containing antibody blood tests at a pre-departure coronavirus disease... 
Sydney, Australia 
A pre-departure COVID-19 testing facility outside the international terminal at Sydney Airport in Sydney... 
A medical worker holds a tray containing antibody blood tests at a pre-departure coronavirus disease (COVID-19) testing facility, as countries react to the new coronavirus Omicron variant, outside the international terminal at Sydney Airport in Sydney, Australia, November 29, 2021. REUTERS/Loren Elliott 
HEALTH-CORONAVIRUS/USA
RTXHL8SK 
September 23, 2021 
A vial of Regeneron monoclonal antibody sits on a medical table as registered nurse Jessica Krumwiede... 
Sarasota, UNITED STATES 
Regeneron monoclonal antibody treatment at Sarasota Memorial Urgent Care Center in Sarasota, Florida 
A vial of Regeneron monoclonal antibody sits on a medical table as registered nurse Jessica Krumwiede attempts to find a vein to administer it to Cathy Hardin, who was vaccinated prior to testing positive for the coronavirus disease (COVID-19), at the Sarasota Memorial Urgent Care Center in Sarasota, Florida, U.S., September 23, 2021. REUTERS/Shannon Stapleton 
HEALTH-CORONAVIRUS/USA
RTXHL8SM 
September 23, 2021 
Registered nurses Johnna Hommell and Jessica Krumwiede attempt to find a vein to administer the Regeneron... 
Sarasota, UNITED STATES 
Regeneron monoclonal antibody treatment at Sarasota Memorial Urgent Care Center in Sarasota, Florida 
Registered nurses Johnna Hommell and Jessica Krumwiede attempt to find a vein to administer the Regeneron monoclonal antibody to Cathy Hardin, who was vaccinated prior to testing positive for the coronavirus disease (COVID-19), at the Sarasota Memorial Urgent Care Center in Sarasota, Florida, U.S., September 23, 2021. REUTERS/Shannon Stapleton 
HEALTH-CORONAVIRUS/USA
RTXHL8SL 
September 23, 2021 
Cathy Hardin, who was vaccinated prior to testing positive for the coronavirus disease (COVID-19), has... 
Sarasota, UNITED STATES 
Regeneron monoclonal antibody treatment at Sarasota Memorial Urgent Care Center in Sarasota, Florida 
Cathy Hardin, who was vaccinated prior to testing positive for the coronavirus disease (COVID-19), has her blood pressure taken before attempting to receive the Regeneron monoclonal antibody treatment at the Sarasota Memorial Urgent Care Center in Sarasota, Florida, U.S., September 23, 2021. REUTERS/Shannon Stapleton 
HEALTH-CORONAVIRUS/USA
RTXHL8M9 
September 23, 2021 
A registered nurse attempts to find a vein to administer the Regeneron monoclonal antibody to Cathy Hardin,... 
Sarasota, UNITED STATES 
Regeneron monoclonal antibody treatment at Sarasota Memorial Urgent Care Center in Sarasota, Florida 
A registered nurse attempts to find a vein to administer the Regeneron monoclonal antibody to Cathy Hardin, who was vaccinated prior to testing positive for the coronavirus disease (COVID-19), at the Sarasota Memorial Urgent Care Center in Sarasota, Florida, U.S., September 23, 2021. REUTERS/Shannon Stapleton TPX IMAGES OF THE DAY 
HEALTH-CORONAVIRUS/USA
RTXHL8GZ 
September 23, 2021 
A vial of Regeneron monoclonal antibody sits on a medical table as registered nurse Jessica Krumwiede... 
Sarasota, UNITED STATES 
Regeneron monoclonal antibody treatment at Sarasota Memorial Urgent Care Center in Sarasota, Florida 
A vial of Regeneron monoclonal antibody sits on a medical table as registered nurse Jessica Krumwiede attempts to find a vein to administer it to Cathy Hardin, who was vaccinated prior to testing positive for the coronavirus disease (COVID-19), at the Sarasota Memorial Urgent Care Center in Sarasota, Florida, U.S., September 23, 2021. REUTERS/Shannon Stapleton 
HEALTH-CORONAVIRUS/USA
RTXHL8H1 
September 23, 2021 
Registered nurse Jessica Krumwiede attempts to find vein to administer the Regeneron monoclonal antibody... 
Sarasota, UNITED STATES 
Regeneron monoclonal antibody treatment at Sarasota Memorial Urgent Care Center in Sarasota, Florida 
Registered nurse Jessica Krumwiede attempts to find vein to administer the Regeneron monoclonal antibody to Cathy Hardin, who was vaccinated prior to testing positive for the coronavirus disease (COVID-19), at the Sarasota Memorial Urgent Care Center in Sarasota, Florida, U.S., September 23, 2021. REUTERS/Shannon Stapleton 
HEALTH-CORONAVIRUS/USA
RTXHL8H0 
September 23, 2021 
Registered nurse Jessica Krumwiede attempts to find vein to administer the Regeneron monoclonal antibody... 
Sarasota, UNITED STATES 
Regeneron monoclonal antibody treatment at Sarasota Memorial Urgent Care Center in Sarasota, Florida 
Registered nurse Jessica Krumwiede attempts to find vein to administer the Regeneron monoclonal antibody to Cathy Hardin, who was vaccinated prior to testing positive for the coronavirus disease (COVID-19), at the Sarasota Memorial Urgent Care Center in Sarasota, Florida, U.S., September 23, 2021. REUTERS/Shannon Stapleton 
HEALTH-CORONAVIRUS/USA
RTXHL8DK 
September 23, 2021 
Registered nurse Jessica Krumwiede attempts to find a vein to administer the Regeneron monoclonal antibody... 
Sarasota, UNITED STATES 
Regeneron monoclonal antibody treatment at Sarasota Memorial Urgent Care Center in Sarasota, Florida 
Registered nurse Jessica Krumwiede attempts to find a vein to administer the Regeneron monoclonal antibody to Cathy Hardin, who was vaccinated prior to testing positive for the coronavirus disease (COVID-19), at the Sarasota Memorial Urgent Care Center in Sarasota, Florida, U.S., September 23, 2021. REUTERS/Shannon Stapleton 
HEALTH-CORONAVIRUS/USA
RTXHL8DH 
September 23, 2021 
Cathy Hardin, who was vaccinated prior to testing positive for the coronavirus disease (COVID-19), has... 
Sarasota, UNITED STATES 
Regeneron monoclonal antibody treatment at Sarasota Memorial Urgent Care Center in Sarasota, Florida 
Cathy Hardin, who was vaccinated prior to testing positive for the coronavirus disease (COVID-19), has her blood pressure taken before attempting to receive the Regeneron monoclonal antibody treatment from registered nurse Jessica Krumwiede at the Sarasota Memorial Urgent Care Center in Sarasota, Florida, U.S., September 23, 2021. REUTERS/Shannon Stapleton 
HEALTH-CORONAVIRUS/USA
RTXHL8DI 
September 23, 2021 
Cathy Hardin, who was vaccinated prior to testing positive for the coronavirus disease (COVID-19), looks... 
Sarasota, UNITED STATES 
Regeneron monoclonal antibody treatment at Sarasota Memorial Urgent Care Center in Sarasota, Florida 
Cathy Hardin, who was vaccinated prior to testing positive for the coronavirus disease (COVID-19), looks up as registered nurse Jessica Krumwiede attempts to find a vein to administer the Regeneron monoclonal antibody to at the Sarasota Memorial Urgent Care Center in Sarasota, Florida, U.S., September 23, 2021. REUTERS/Shannon Stapleton 
HEALTH-CORONAVIRUS/USA
RTXHL8DJ 
September 23, 2021 
Cathy Hardin, who was vaccinated prior to testing positive for the coronavirus disease (COVID-19), waits... 
Sarasota, UNITED STATES 
Regeneron monoclonal antibody treatment at Sarasota Memorial Urgent Care Center in Sarasota, Florida 
Cathy Hardin, who was vaccinated prior to testing positive for the coronavirus disease (COVID-19), waits for the Regeneron monoclonal antibody treatment at the Sarasota Memorial Urgent Care Center in Sarasota, Florida, U.S., September 23, 2021. REUTERS/Shannon Stapleton 
HEALTH-CORONAVIRUS/USA
RTXHL89X 
September 23, 2021 
A registered nurse attempts to find a vein to administer the Regeneron monoclonal antibody to Cathy Hardin,... 
Sarasota, UNITED STATES 
Regeneron monoclonal antibody treatment at Sarasota Memorial Urgent Care Center in Sarasota, Florida 
A registered nurse attempts to find a vein to administer the Regeneron monoclonal antibody to Cathy Hardin, who was vaccinated prior to testing positive for the coronavirus disease (COVID-19), at the Sarasota Memorial Urgent Care Center in Sarasota, Florida, U.S., September 23, 2021. REUTERS/Shannon Stapleton 
HEALTH-CORONAVIRUS/USA
RTXHL6KF 
September 23, 2021 
Registered nurse Jessica Krumwiede attempts to find a vein to administer the Regeneron monoclonal antibody... 
Sarasota, UNITED STATES 
Regeneron monoclonal antibody treatment at Sarasota Memorial Urgent Care Center in Sarasota, Florida 
Registered nurse Jessica Krumwiede attempts to find a vein to administer the Regeneron monoclonal antibody to Cathy Hardin, who was vaccinated prior to testing positive for the coronavirus disease (COVID-19), at the Sarasota Memorial Urgent Care Center in Sarasota, Florida, U.S., September 23, 2021. REUTERS/Shannon Stapleton 
HEALTH-CORONAVIRUS/USA
RTXHL6KE 
September 23, 2021 
Cathy Hardin, who was vaccinated prior to testing positive for the coronavirus disease (COVID-19), has... 
Sarasota, UNITED STATES 
Regeneron monoclonal antibody treatment at Sarasota Memorial Urgent Care Center in Sarasota, Florida 
Cathy Hardin, who was vaccinated prior to testing positive for the coronavirus disease (COVID-19), has her blood pressure taken before attempting to receive the Regeneron monoclonal antibody treatment from registered nurse Jessica Krumwiede at the Sarasota Memorial Urgent Care Center in Sarasota, Florida, U.S., September 23, 2021. REUTERS/Shannon Stapleton 
HEALTH-CORONAVIRUS/USA
RTXHL6K9 
September 23, 2021 
Registered nurse Jessica Krumwiede attempts to find a vein to administer the Regeneron monoclonal antibody... 
Sarasota, UNITED STATES 
Regeneron monoclonal antibody treatment at Sarasota Memorial Urgent Care Center in Sarasota, Florida 
Registered nurse Jessica Krumwiede attempts to find a vein to administer the Regeneron monoclonal antibody to Cathy Hardin, who was vaccinated prior to testing positive for the coronavirus disease (COVID-19), at the Sarasota Memorial Urgent Care Center in Sarasota, Florida, U.S., September 23, 2021. REUTERS/Shannon Stapleton 
HEALTH-CORONAVIRUS/USA
RTXHL6KB 
September 23, 2021 
Registered nurse Jessica Krumwiede attempts to find a vein to administer the Regeneron monoclonal antibody... 
Sarasota, UNITED STATES 
Regeneron monoclonal antibody treatment at Sarasota Memorial Urgent Care Center in Sarasota, Florida 
Registered nurse Jessica Krumwiede attempts to find a vein to administer the Regeneron monoclonal antibody to Cathy Hardin, who was vaccinated prior to testing positive for the coronavirus disease (COVID-19), at the Sarasota Memorial Urgent Care Center in Sarasota, Florida, U.S., September 23, 2021. REUTERS/Shannon Stapleton 
HEALTH-CORONAVIRUS/USA
RTXHL6KA 
September 23, 2021 
The Regeneron monoclonal antibody sits on a medical table as registered nurse Jessica Krumwiede attempts... 
Sarasota, UNITED STATES 
Regeneron monoclonal antibody treatment at Sarasota Memorial Urgent Care Center in Sarasota, Florida 
The Regeneron monoclonal antibody sits on a medical table as registered nurse Jessica Krumwiede attempts to find a vein to administer it to Cathy Hardin, who was vaccinated prior to testing positive for the coronavirus disease (COVID-19), at the Sarasota Memorial Urgent Care Center in Sarasota, Florida, U.S., September 23, 2021. REUTERS/Shannon Stapleton 
HEALTH-CORONAVIRUS/STUDY-TESTS
RTXGZCE9 
September 10, 2021 
A specimen collection kit mailed in September 2021 to patients with blood cancers enrolled in the IMPACT... 
Chatham, UNITED STATES 
An IMPACT study specimen collection kit is seen in Chatham, New Jersey 
A specimen collection kit mailed in September 2021 to patients with blood cancers enrolled in the IMPACT study (Immune Profiling with Antibody-based COVID-19 Testing), being conducted by the Dana Farber Cancer Institute and Quest Diagnostics to shed light on how these patients' immune systems may interact with the SARS-CoV-2 virus or the vaccines, is seen in Chatham, New Jersey, U.S. September 10, 2021. REUTERS/Nancy Lapid 
HEALTH-CORONAVIRUS/STUDY-TESTS
RTXGZCDW 
September 10, 2021 
A specimen collection kit mailed in September 2021 to patients with blood cancers enrolled in the IMPACT... 
Chatham, UNITED STATES 
An IMPACT study specimen collection kit is seen in Chatham, New Jersey 
A specimen collection kit mailed in September 2021 to patients with blood cancers enrolled in the IMPACT study (Immune Profiling with Antibody-based COVID-19 Testing), being conducted by the Dana Farber Cancer Institute and Quest Diagnostics to shed light on how these patients' immune systems may interact with the SARS-CoV-2 virus or the vaccines, is seen in Chatham, New Jersey, U.S. September 10, 2021. REUTERS/Nancy Lapid 
HEALTH-CORONAVIRUS/STUDY-TESTS
RTXGZCDY 
September 10, 2021 
A specimen collection kit mailed in September 2021 to patients with blood cancers enrolled in the IMPACT... 
Chatham, UNITED STATES 
An IMPACT study specimen collection kit is seen in Chatham, New Jersey 
A specimen collection kit mailed in September 2021 to patients with blood cancers enrolled in the IMPACT study (Immune Profiling with Antibody-based COVID-19 Testing), being conducted by the Dana Farber Cancer Institute and Quest Diagnostics to shed light on how these patients' immune systems may interact with the SARS-CoV-2 virus or the vaccines, is seen in Chatham, New Jersey, U.S. September 10, 2021. REUTERS/Nancy Lapid 
HEALTH-CORONAVIRUS/MEDICINE-LLAMA
RTXG3D5O 
August 23, 2021 
Dr. Xavier Saelens (VIB-UGent Center for Medical Biotechnology group leader) shows an enlarged 3D model... 
Ghent, Belgium 
Dr. Xavier Saelens shows an enlarged 3D model of a spike protein connected to an antibody in Ghent 
Dr. Xavier Saelens (VIB-UGent Center for Medical Biotechnology group leader) shows an enlarged 3D model of a spike protein (blue) connected to an antibody (red), amid the coronavirus disease (COVID-19) pandemic, in Ghent, Belgium August 23, 2021. REUTERS/ Bart Biesemans 
HEALTH-CORONAVIRUS/MEDICINE-LLAMA
RTXG3D32 
August 23, 2021 
An enlarged 3D model of a spike protein (blue) connected to an antibody (red) sits on a table in VIB-UGent... 
Ghent, Belgium 
An enlarged 3D model of a spike protein connected to an antibody sits on a table in VIB-UGent Center... 
An enlarged 3D model of a spike protein (blue) connected to an antibody (red) sits on a table in VIB-UGent Center, amid the coronavirus disease (COVID-19) pandemic, in Ghent, Belgium August 23, 2021. REUTERS/Bart Biesemans 
HEALTH-CORONAVIRUS/MEDICINE-LLAMA
RTXG3D2K 
August 23, 2021 
ExeVir. Bio BV Chief medical officer Dominique Tersago, Dr. Bert Schepens (VIB-UGent Center for Medical... 
Ghent, Belgium 
ExeVir. Bio BV Chief medical officer Dominique Tersago, Dr. Bert Schepens, Dr. Xavier Saelens and Dr.... 
ExeVir. Bio BV Chief medical officer Dominique Tersago, Dr. Bert Schepens (VIB-UGent Center for Medical Biotechnology research), Dr. Xavier Saelens (VIB-UGent Center for Medical Biotechnology group leader) and Dr. Nico Callewaert (director of the VIB-UGent Center for Medical Biotechnology) show an enlarged 3D model of a spike protein (blue) connected to an antibody (red) in Ghent, Belgium August 23, 2021. REUTERS/ Bart Biesemans 
HEALTH-CORONAVIRUS/MEDICINE-LLAMA
RTXG3D2O 
August 23, 2021 
A llama called Winter, whose antibodies were used in the hunt for a treatment for the coronavirus disease... 
Genk, Belgium 
A llama called Winter, whose antibodies were used in the hunt for a treatment for COVID-19 
A llama called Winter, whose antibodies were used in the hunt for a treatment for the coronavirus disease (COVID-19), stands in a meadow in Genk, Belgium August 23, 2021. REUTERS/Johanna Geron 
HEALTH-CORONAVIRUS/MEDICINE-LLAMA
RTXG3D2M 
August 23, 2021 
A llama called Winter, whose antibodies were used in the hunt for a treatment for the coronavirus disease... 
Genk, Belgium 
A llama called Winter, whose antibodies were used in the hunt for a treatment for COVID-19 
A llama called Winter, whose antibodies were used in the hunt for a treatment for the coronavirus disease (COVID-19), stands in a meadow in Genk, Belgium August 23, 2021. REUTERS/ Johanna Geron TPX IMAGES OF THE DAY 
HEALTH-CORONAVIRUS/MEDICINE-LLAMA
RTXG3D2S 
August 23, 2021 
A llama called Winter, whose antibodies were used in the hunt for a treatment for the coronavirus disease... 
Genk, Belgium 
A llama called Winter, whose antibodies were used in the hunt for a treatment for COVID-19 
A llama called Winter, whose antibodies were used in the hunt for a treatment for the coronavirus disease (COVID-19), stands in a meadow in Genk, Belgium August 23, 2021. REUTERS/ Johanna Geron 
HEALTH-CORONAVIRUS/MEDICINE-LLAMA
RTXG3D2Y 
August 23, 2021 
A llama called Winter, whose antibodies were used in the hunt for a treatment for the coronavirus disease... 
Genk, Belgium 
A llama called Winter, whose antibodies were used in the hunt for a treatment for COVID-19 
A llama called Winter, whose antibodies were used in the hunt for a treatment for the coronavirus disease (COVID-19), stands in a meadow in Genk, Belgium August 23, 2021. REUTERS/ Johanna Geron 
HEALTH-CORONAVIRUS/MEDICINE-LLAMA
RTXG3D2R 
August 23, 2021 
A llama called Winter, whose antibodies were used in the hunt for a treatment for the coronavirus disease... 
Genk, Belgium 
A llama called Winter, whose antibodies were used in the hunt for a treatment for COVID-19 
A llama called Winter, whose antibodies were used in the hunt for a treatment for the coronavirus disease (COVID-19), stands in a meadow in Genk, Belgium August 23, 2021. REUTERS/ Johanna Geron 
HEALTH-CORONAVIRUS/MEDICINE-LLAMA
RTXG3D2U 
August 23, 2021 
A llama called Winter, whose antibodies were used in the hunt for a treatment for the coronavirus disease... 
Genk, Belgium 
A llama called Winter, whose antibodies were used in the hunt for a treatment for COVID-19 
A llama called Winter, whose antibodies were used in the hunt for a treatment for the coronavirus disease (COVID-19), stands in a meadow in Genk, Belgium August 23, 2021. REUTERS/ Johanna Geron 
HEALTH-CORONAVIRUS/ITALY-ANTIBODIES
RTXBPINB 
April 22, 2021 
A health worker holds up a vial of Imdevimab, an antibody cocktail designed to produce resistance to... 
Albano, Italy 
Albano hospital begins monoclonal antibody treatment for COVID-19 patients 
A health worker holds up a vial of Imdevimab, an antibody cocktail designed to produce resistance to the coronavirus disease (COVID-19), at San Giuseppe Hospital, in Albano, Italy, April 22, 2021. REUTERS/Yara Nardi 
HEALTH-CORONAVIRUS/ITALY-ANTIBODIES
RTXBPINA 
April 22, 2021 
A health worker checks the parameters of Andrea Sconocchia, a coronavirus disease (COVID-19) patient,... 
Albano, Italy 
Albano hospital begins monoclonal antibody treatment for COVID-19 patients 
A health worker checks the parameters of Andrea Sconocchia, a coronavirus disease (COVID-19) patient, before giving him an intravenous administration of a monoclonal antibody treatment, at San Giuseppe Hospital, in Albano, Italy, April 22, 2021. REUTERS/Yara Nardi 
HEALTH-CORONAVIRUS/ITALY-ANTIBODIES
RTXBPIIA 
April 22, 2021 
A health worker looks on as coronavirus disease (COVID-19) patients undergo intravenous monoclonal antibody... 
Albano, Italy 
Albano hospital begins monoclonal antibody treatment for COVID-19 patients 
A health worker looks on as coronavirus disease (COVID-19) patients undergo intravenous monoclonal antibody treatment, at San Giuseppe Hospital, in Albano, Italy, April 22, 2021. REUTERS/Yara Nardi 
HEALTH-CORONAVIRUS/ITALY-ANTIBODIES
RTXBPIEP 
April 22, 2021 
A medical health worker administers an intravenous dose of monoclonal antibody treatment to Antonio Rapuano,... 
Albano, Italy 
Albano hospital begins monoclonal antibody treatment for Covid patients 
A medical health worker administers an intravenous dose of monoclonal antibody treatment to Antonio Rapuano, a coronavirus disease (COVID-19) patient, at San Giuseppe Hospital, in Albano, Italy, April 22, 2021. REUTERS/Yara Nardi 
HEALTH-CORONAVIRUS/ITALY-ANTIBODIES
RTXBPICI 
April 22, 2021 
A health worker looks at an infusion bottle containing a monoclonal antibody treatment as it is being... 
Albano, Italy 
Albano hospital begins monoclonal antibody treatment for Covid patients 
A health worker looks at an infusion bottle containing a monoclonal antibody treatment as it is being administered intravenously to a coronavirus disease (COVID-19) patient, at San Giuseppe Hospital, in Albano, Italy, April 22, 2021. REUTERS/Yara Nardi 
HEALTH-CORONAVIRUS/ITALY-ANTIBODIES
RTXBPIAY 
April 22, 2021 
Antonio Rapuano, a coronavirus disease (COVID-19) patient, looks on as a health worker preps him to receive... 
Albano, Italy 
Albano hospital begins monoclonal antibody treatment for (COVID-19) patients 
Antonio Rapuano, a coronavirus disease (COVID-19) patient, looks on as a health worker preps him to receive an intravenous dose of monoclonal antibody treatment, at San Giuseppe Hospital, in Albano, Italy, April 22, 2021. REUTERS/Yara Nardi 
HEALTH-CORONAVIRUS/ITALY-ANTIBODIES
RTXBPI6G 
April 22, 2021 
A health worker smiles at Antonio Rapuano, a coronavirus disease (COVID-19) patient, as he is administered... 
Albano, Italy 
Albano hospital begins monoclonal antibody treatment for COVID-19 patients 
A health worker smiles at Antonio Rapuano, a coronavirus disease (COVID-19) patient, as he is administered the monoclonal antibody treatment intravenously, at San Giuseppe Hospital, in Albano, Italy, April 22, 2021. REUTERS/Yara Nardi 
HEALTH-CORONAVIRUS/ITALY-ANTIBODIES
RTXBPHWD 
April 22, 2021 
A health worker looks at an infusion bottle containing a monoclonal antibody treatment as it is being... 
Albano, Italy 
Albano hospital begins monoclonal antibody treatment for COVID-19 patients 
A health worker looks at an infusion bottle containing a monoclonal antibody treatment as it is being administered intravenously to a coronavirus disease (COVID-19) patient, at San Giuseppe Hospital, in Albano, Italy, April 22, 2021. REUTERS/Yara Nardi 
HEALTH-CORONAVIRUS/ITALY-ANTIBODIES
RTXBPHWC 
April 22, 2021 
A health worker looks at Andrea Sconocchia, a coronavirus disease (COVID-19) patient, as he is administered... 
Albano, Italy 
Albano hospital begins monoclonal antibody treatment for Covid patients 
A health worker looks at Andrea Sconocchia, a coronavirus disease (COVID-19) patient, as he is administered the monoclonal antibody treatment intravenously, at San Giuseppe Hospital, in Albano, Italy, April 22, 2021. REUTERS/Yara Nardi 
HEALTH-CORONAVIRUS/ITALY-ANTIBODIES
RTXBPHI3 
April 22, 2021 
Andrea Sconocchia, coronavirus disease (COVID-19) patient, looks on as a health worker prepares a monoclonal... 
Albano, Italy 
Albano hospital begins monoclonal antibody treatment for COVID-19 patients 
Andrea Sconocchia, coronavirus disease (COVID-19) patient, looks on as a health worker prepares a monoclonal antibody treatment before giving him an intravenous administration of the drug, at San Giuseppe Hospital, in Albano, Italy, April 22, 2021. REUTERS/Yara Nardi 
HEALTH-CORONAVIRUS/ITALY-ANTIBODIES
RTXBPHHW 
April 22, 2021 
Andrea Sconocchia, coronavirus disease (COVID-19) patient, looks on as he is administered the monoclonal... 
Albano, Italy 
Albano hospital begins monoclonal antibody treatment for COVID-19 patients 
Andrea Sconocchia, coronavirus disease (COVID-19) patient, looks on as he is administered the monoclonal antibody treatment intravenously, at San Giuseppe Hospital, in Albano, Italy, April 22, 2021. REUTERS/Yara Nardi 
HEALTH-CORONAVIRUS/ITALY-ANTIBODIES
RTXBPHBW 
April 22, 2021 
Antonio Rapuano, coronavirus disease (COVID-19) patient, looks on as a health worker prepares a monoclonal... 
Albano, Italy 
Albano hospital begins monoclonal antibody treatment for COVID-19 patients 
Antonio Rapuano, coronavirus disease (COVID-19) patient, looks on as a health worker prepares a monoclonal antibody treatment before giving him an intravenous administration of the drug, at San Giuseppe Hospital, in Albano, Italy, April 22, 2021. REUTERS/Yara Nardi 
HEALTH-CORONAVIRUS/MONOCLONAL ANTIBODY
RTXBMCSQ 
April 19, 2021 
Health professionals and local politicians pose for a Alejandra Perez to take a picture as they gather... 
Chula Vista, UNITED STATES 
Monoclonal antibody treatment for COVID-19 positive individuals opens in former fire station in California... 
Health professionals and local politicians pose for a Alejandra Perez to take a picture as they gather to open a free monoclonal antibody treatment center for COVID-19 positive individuals at a former fire station in Chula Vista, California, U.S., April 19, 2021. REUTERS/Mike Blake 
HEALTH-CORONAVIRUS/MONOCLONAL ANTIBODY
RTXBMCSO 
April 19, 2021 
A healthcare worker waits outside outside a former fire station that opened today as a monoclonal antibody... 
Chula Vista, UNITED STATES 
Monoclonal antibody treatment for COVID-19 positive individuals opens in former fire station in California... 
A healthcare worker waits outside outside a former fire station that opened today as a monoclonal antibody treatment center for COVID-19 positive individuals in Chula Vista, California, U.S., April 19, 2021. REUTERS/Mike Blake 
HEALTH-CORONAVIRUS/SPAIN-CHRISTMAS
RTX8I66Y 
December 24, 2020 
The coronavirus disease (COVID-19) survivor Santiaga Cerrato, 85, who suffers from Alzheimer’s disease,... 
NAVALCARNERO, Spain 
COVID-19 survivor Santiaga Cerrato, 85, who suffers from Alzheimer’s disease, says good-bye upon leaving... 
The coronavirus disease (COVID-19) survivor Santiaga Cerrato, 85, who suffers from Alzheimer’s disease, says good-bye upon leaving the nursing home Centro Casaverde in Navalcarnero, outside Madrid, Spain, December 23, 2020. Under the Madrid region's coronavirus restrictions elderly residents like Santiaga are allowed to visit family over the holidays if they have coronavirus antibodies that can guarantee their immunity to the disease. Cerrato will have to undergo diagnostic and antibodies tests prior to going back to the nursing home to determine whether she must observe a quarantine period upon her return. Picture taken December 23, 2020. REUTERS/Susana Vera 
HEALTH-CORONAVIRUS/SPAIN-CHRISTMAS
RTX8I66X 
December 24, 2020 
The coronavirus disease (COVID-19) survivor Santiaga Cerrato, 85, who suffers from Alzheimer?s disease,... 
NAVALCARNERO, Spain 
COVID-19 survivor Santiaga Cerrato, 85, who suffers from Alzheimer’s disease, bids farewell to fellow... 
The coronavirus disease (COVID-19) survivor Santiaga Cerrato, 85, who suffers from Alzheimer?s disease, bids farewell to fellow resident Antonia Sanchez at the nursing home Centro Casaverde in Navalcarnero, outside Madrid, Spain, December 23, 2020. Under the Madrid region's coronavirus restrictions elderly residents like Santiaga are allowed to visit family over the holidays if they have coronavirus antibodies that can guarantee their immunity to the disease. Cerrato will have to undergo diagnostic and antibodies tests prior to going back to the nursing home to determine whether she must observe a quarantine period upon her return. Picture taken December 23, 2020. REUTERS/Susana Vera TPX IMAGES OF THE DAY 
HEALTH-CORONAVIRUS/SPAIN-CHRISTMAS
RTX8I66O 
December 24, 2020 
The coronavirus disease (COVID-19) survivor Santiaga Cerrato, 85, who suffers from Alzheimer?s disease,... 
NAVALCARNERO, Spain 
COVID-19 survivor Santiaga Cerrato, 85, who suffers from Alzheimer’s disease, waits for the arrival of... 
The coronavirus disease (COVID-19) survivor Santiaga Cerrato, 85, who suffers from Alzheimer?s disease, waits for the arrival of her son at the nursing home Centro Casaverde in Navalcarnero, outside Madrid, Spain, December 23, 2020. Under the Madrid region's coronavirus restrictions elderly residents like Santiaga are allowed to visit family over the holidays if they have coronavirus antibodies that can guarantee their immunity to the disease. Cerrato will have to undergo diagnostic and antibodies tests prior to going back to the nursing home to determine whether she must observe a quarantine period upon her return. Picture taken December 23, 2020. REUTERS/Susana Vera 
HEALTH-CORONAVIRUS/SPAIN-CHRISTMAS
RTX8I66P 
December 24, 2020 
The coronavirus disease (COVID-19) survivor Santiaga Cerrato, 85, who suffers from Alzheimer?s disease,... 
NAVALCARNERO, Spain 
COVID-19 survivor Santiaga Cerrato, 85, who suffers from Alzheimer’s disease, waits for the arrival of... 
The coronavirus disease (COVID-19) survivor Santiaga Cerrato, 85, who suffers from Alzheimer?s disease, waits for the arrival of her son at the nursing home Centro Casaverde in Navalcarnero, outside Madrid, Spain, December 23, 2020. Under the Madrid region's coronavirus restrictions elderly residents like Santiaga are allowed to visit family over the holidays if they have coronavirus antibodies that can guarantee their immunity to the disease. Cerrato will have to undergo diagnostic and antibodies tests prior to going back to the nursing home to determine whether she must observe a quarantine period upon her return. Picture taken December 23, 2020. REUTERS/Susana Vera 
HEALTH-CORONAVIRUS/SPAIN-CHRISTMAS
RTX8I66R 
December 24, 2020 
The coronavirus disease (COVID-19) survivor Santiaga Cerrato, 85, who suffers from Alzheimer?s disease,... 
NAVALCARNERO, Spain 
COVID-19 survivor Santiaga Cerrato, 85, who suffers from Alzheimer’s disease, waits for the arrival of... 
The coronavirus disease (COVID-19) survivor Santiaga Cerrato, 85, who suffers from Alzheimer?s disease, waits for the arrival of her son at the nursing home Centro Casaverde in Navalcarnero, outside Madrid, Spain, December 23, 2020. Under the Madrid region's coronavirus restrictions elderly residents like Santiaga are allowed to visit family over the holidays if they have coronavirus antibodies that can guarantee their immunity to the disease. Cerrato will have to undergo diagnostic and antibodies tests prior to going back to the nursing home to determine whether she must observe a quarantine period upon her return. Picture taken December 23, 2020. REUTERS/Susana Vera 
Sort by 
Display 
Items per page 
Page 
of 8